InovoBiologic Inc.   Report issue

For profit Phase 3
Founded: Burnaby BC Canada (2002)

Organization Overview

First Clinical Trial
2006
NCT00801814
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

oryza sativa (2 trials)

polyglycoplex (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Overweight (Phase 3)

Weight Loss (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 2